ArticleBMC oral health2025
pH-Responsive mesoporous silica nanoparticle-reinforced composite resin with remineralization capability.
Article in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Bioactive Fillers in Bulk-Fill Composite Resins: A Comprehensive Review of the Effects on Polymerization Shrinkage Behavior and Mechanical Performance.Materials (Basel, Switzerland) · 2026Review
- Advanced biomimetic mineralization approaches for enamel and dentin regeneration: a review.Odontology · 2026Review
- Recent perspectives on precision-targeting therapy against oral biofilm.Journal of oral microbiology · 2026Review
- Application of Amorphous Nanomaterials in Dentistry: A Comprehensive Review.Journal of functional biomaterials · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveEnhancing the mechanical properties of composite resins and promoting dentin remineralization are effective strategies for extending the longevity of restorations. In this study, we developed a pH-responsive composite resin reinforced with phosphorylated chitosan (Pchi)/amorphous calcium phosphate (ACP) and amino-functionalized mesoporous silica nanoparticles (MSNs) (Pchi/ACP@A-MSN complexes).
methodsMSNs and Pchi/ACP were synthesized, and the resulting composite resins were classified into five groups based on the filler compositions: Group A (45wt.% A-MSNs + 15wt.% Pchi/ACP + 40wt.% resin matrix), Group B (22.5wt.% A-MSNs + 37.5wt.% Pchi/ACP@A-MSNs + 40wt.% resin matrix), Group C (45wt.% nonporous silica + 15wt.% Pchi/ACP + 40wt.% resin matrix), Group D (15wt.% Pchi/ACP + 85wt.% resin matrix), and Group E (100wt.% resin matrix). The degree of double-bond conversion and mechanical properties (Flexural modulus, flexural strength, and Vickers hardness) of each group were measured. The remineralization performance and calcium ion (Ca²⁺) release performance were observed. Cell viability was evaluated by CCK-8 assay.
resultsGroup A exhibited the highest mechanical performance, with flexural strength of 115 ± 9.68 MPa, flexural modulus of 5.99 ± 0.44 GPa, and Vickers hardness of 31.73 ± 2.39 HV. All groups achieved double-bond conversion rates > 50% after 60 s of light curing (P > 0.05). At pH 4.0, Group B exhibited the highest Ca²⁺ release (276 µg/mL), while Group D had the highest release at pH 7.4 (128 µg/mL). SEM and EDS analyses indicated that Group D achieved the most substantial dentin remineralization, followed by Groups C and A. All groups maintained cell viability above 75% throughout the 7-day assay, with no significant cytotoxicity observed.
conclusionA composite formulation containing 45 wt% A-MSNs and 15 wt% Pchi/ACP (Group A) significantly enhanced mechanical strength. The 15 wt% Pchi/ACP formulation (Group D) demonstrated the greatest remineralization effect. Group B, combining A-MSNs and Pchi/ACP@A-MSNs, provided pH-responsive Ca²⁺ release with a favorable balance of mechanical performance and remineralization potential. All formulations met the biocompatibility requirements for dental applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.